Join
Live feed
·
INSIDERFilingvia Quantisnow
Neumora Therapeutics Inc. logo

Head of R&D Lenz Robert A. sold $9,383 worth of shares (5,614 units at $1.67), decreasing direct ownership by 2% to 309,092 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
NMRA· Neumora Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NMRA (Neumora Therapeutics Inc.) and more on Quantisnow.